MYC and breast cancer: These results suggest that, in breast cancer cells, circAMOTL1 acts as a scaffold for c-MYC protein, facilitating its nuclear translocation (which also protects c-MYC from degradation), upregulating c-MYC targets, and, as the outcome, promoting cancer growth (Figure 4).